Global Tolterodine Market Size, Share and Trends Analysis Report, By Type (Natural, Synthetic, and Semi-synthetic), By Dosage Form (Tablets and Capsules), By Application (Urinary Incontinence, Respiratory Disease, and Gastrointestinal Disease), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Forecast (2022-2028)

The global tolterodine market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Tolterodine is the medication that can be used for the treatment of urinary incontinence, a disease in which the bladder gets overactive and the frequency of urine is increased without any control on the bladder. The major factor attributable to the growth of the market is the increasing demand for tolterodine medicine for the treatment of the increasing prevalence of urinary incontinence. In addition, the market players are constantly developing tolterodine medicine for better treatment. According to an article published on Medical News Today on June 17, 2022, medical experts suggest doctors to prescribe several medicines including tolterodine to relax the overactive bladder problem.
In addition, an increasing number of patients with urinary incontinence and several gastrointestinal and respiratory disease is further supporting in the growth of the global tolterodine market. According to a report published by Female Pelvic Medicine & Reconstructive Surgery (FPMRS) in 2022, there are more than 60% of women in the US suffer from any type of urinary incontinence. The report also shows that more than 20% of the women are experiencing moderate to severe urinary incontinence due to several reasons including aging, increasing obesity, body mass index greater than 40, and vaginal births. Furthermore, increasing patients with the gastrointestinal disease are also increasing the demand for tolterodine medicine for the treatments. According to a report published by the National Library of Medicine in January 2022, the study found that around 40% of people are suffering from functional gastrointestinal diseases. According to World Health Org. (WHO), there are around 65 million people suffering from the chronic obstructive pulmonary disease (COPD), a type of respiratory disease. The mortality rate of COPD is around 3 million people each year.
Tolterodine comes in three types including natural tolterodine, synthetic tolterodine, and semi-synthetic tolterodine as oral dosage forms such as tablets and capsules. It can be reached through various distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies. The increasing number of several diseases as described above is one of the factors propelling the growth of the global tolterodine market.
Some major players in the market include Teva Pharmaceuticals Industries Ltd., Novartis International AG, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2022, Camber Pharmaceuticals launched tolterodine tartrate IR tablets expanding their portfolio. Tolterodine tartrate IR tablets are the generic version of ‘Detrol’ and are used for the treatment of overactive bladder. These tablets are available in both 1mg and 2mg strength with the bottle of 60 tablet counts. In addition, in August 2022, the US Food and Drug Administration (FDA) approved a generic version of Detrol called ‘tolterodine tartrate tablets’ for manufacturing by Hetero Labs Ltd. V.

Market Coverage
The market number available for – 2022-2028
Base year- 2022
Forecast period- 2022-2028
Segment Covered-
By Dosage Form
By Application
By Distribution Channel
By Type
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Top Major Key Players:
Teva Pharmaceuticals Industries Ltd., Novartis International AG, Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., and Pfizer Inc., among others.

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

 

Global Tolterodine Market Report by Segment
By Type
Natural Tolterodine
Synthetic Tolterodine
Semi-synthetic Tolterodine
By Dosage Form
Tablets
Capsules
By Application
Urinary Inconsistence
Respiratory Disease
Gastrointestinal Disease
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies